Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Change in Cash: 2019-2024

Historic Change in Cash for Agilon Health (AGL) over the last 6 years, with FY2024 value amounting to $79.5 million.

  • Agilon Health's Change in Cash fell 9928.45% to $268000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$77.4 million, marking a year-over-year decrease of 27721.94%. This contributed to the annual value of $79.5 million for FY2024, which is 12021.88% up from last year.
  • Latest data reveals that Agilon Health reported Change in Cash of $79.5 million as of FY2024, which was up 12021.88% from -$393.4 million recorded in FY2023.
  • In the past 5 years, Agilon Health's Change in Cash registered a high of $915.7 million during FY2021, and its lowest value of -$547.1 million during FY2022.
  • For the 5-year period, Agilon Health's Change in Cash averaged around $9.6 million, with its median value being -$6.5 million (2020).
  • Its Change in Cash has fluctuated over the past 5 years, first surged by 1415132.73% in 2021, then plummeted by 15974.94% in 2022.
  • Annual analysis of 5 years shows Agilon Health's Change in Cash stood at -$6.5 million in 2020, then soared by 14151.33% to $915.7 million in 2021, then plummeted by 159.75% to -$547.1 million in 2022, then increased by 28.11% to -$393.4 million in 2023, then soared by 120.22% to $79.5 million in 2024.
  • Its Change in Cash stands at $79.5 million for FY2024, versus -$393.4 million for FY2023 and -$547.1 million for FY2022.